September 15th 2025
FLAURA2 data show osimertinib plus chemotherapy significantly improves overall survival vs osimertinib alone in frontline EGFR+ advanced NSCLC.
September 12th 2025
Aprepitant Shows Promise for Managing Cough in Lung Cancer
October 12th 2015The antiemetic NK-1 antagonist aprepitant (Emend) was shown to significantly reduce cough in patients with lung cancer, according to findings of the first antitussive trial in patients with lung cancer using objective quantification of cough.
Most Young Lung Cancer Patients Have Actionable Mutations
September 9th 2015A preliminary analysis of an ongoing study shows that most patients diagnosed with lung cancer before age 40 had an increased chance for a targeted genomic alteration, knowledge of which could lead to more effective, targeted treatment.
Study Points to Possible Role for Statins in Lung Cancer
May 13th 2015Statin use before or after a diagnosis of lung cancer may be linked to a reduced risk of death from the disease, according to findings of a recent study which found that patients who used statins in the year before a lung cancer diagnosis had a statistically significant 12% reduction in lung cancer-specific deaths.
E-cigarette Users Nearly 60% Less Likely To Quit Than Traditional Cigarette Smokers
May 11th 2015E-cigarettes, championed by some as a smoking-cessation tool, may actually decrease the likelihood of quitting smoking, according to a recent population-based study of 1000 smokers published in The American Journal of Public Health.
Navigation Program Increases Uptake of Lung Cancer Screening and Facilitates Follow-Up
April 29th 2015A nurse navigator–led program aimed at improving awareness, access, and uptake of low-dose CT screening for individuals at high risk of lung cancer resulted in improved screening rates with the potential to improve patient outcomes by catching the disease at its earliest stages.
High Fitness Level in Older Men Associated with Lower Risk of Some Cancers
March 27th 2015A new study has shown that men with a high fitness level in midlife are not only at a lower risk of developing lung and colorectal cancer, they're also at a lower risk of dying from cancer if they're diagnosed later in life.
Dr. Evans on the Importance of Integrating Palliative Care Early for Advanced Lung Cancer Patients
March 4th 2015Tracey L. Evans, MD associate professor, clinical medicine, Abramson Cancer Center, University of Pennsylvania Health System, discusses the benefit of advanced lung cancer patients receiving palliative care early in their diagnosis.
To Prescribe or Not to Prescribe?: Pain Management for Post-Thoracotomy Patients
December 26th 2014Many patients choose not to call their providers, stating their fear of being labeled "drug seeking" or a "wimp," believing that since they were given no refills for their pain medication, the expectation must be that they should not need more when they run out.
Lung Cancer Foundation App Helps Patients Navigate Care, Diagnosis and Treatment Options
December 23rd 2014The Bonnie J. Addario Lung Cancer Foundation (ALCF), in collaboration with Open Health Network (OHN), announced the launch of Lung Cancer Foundation, the first of its kind mobile application designed to empower lung cancer patients and their families.
For Patients With Inoperable Stage I NSCLC, Race, Hospital, and Insurance Status Matter
December 2nd 2014Despite the proven benefits of SBRT for patients with inoperable stage I NSCLC, whether such patients are offered it depends on their race, insurance status, and the type of facility where they are being treated.
CMS to Cover Annual Lung Cancer Screening for Some High-Risk Patients
November 14th 2014The Centers for Medicare & Medicaid Services (CMS) announced that the agency plans to cover lung cancer screening using low-dose computed tomography (LDCT) for certain former and current smokers, a decision that could affect an estimated 4 million people.
Moving Proactively to Manage AEs With Targeted Lung Cancer Therapies
November 5th 2014At the 2014 Multidisciplinary Symposium in Thoracic Oncology in Chicago, Jyoti D. Patel, MD, associate professor in Medicine-Hematology/Oncology at the Feinberg School of Medicine at Northwestern University, led a breakout session on how to manage the toxicities associated with the molecular therapies used to treat patients with lung cancers.